Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C6H10O7.C4H11NO2 |
| Molecular Weight | 299.275 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OCCNCCO.O[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O
InChI
InChIKey=XQUKNPFXQIBKCF-JSCKKFHOSA-N
InChI=1S/C6H10O7.C4H11NO2/c7-1-2(8)3(9)4(10)5(11)6(12)13;6-3-1-5-2-4-7/h1-5,8-11H,(H,12,13);5-7H,1-4H2/t2-,3+,4-,5-;/m0./s1
| Molecular Formula | C4H11NO2 |
| Molecular Weight | 105.1356 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C6H10O7 |
| Molecular Weight | 194.1394 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Glucuronic acid is a sugar acid that was first identified in urine. It is an intermediate metabolite of the uronic acid pathway. Moreover, glucuronic acid is involved in detoxification of certain drugs and toxins by conjugating with them and forming glucuronides. Glucuronic acid has been found to cause an increase in TLR4-dependent reporter protein expression in a cell line transfected with TLR4 and associated co-signaling molecules, and can cause TLR4-dependent pain in humans.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| An electro-active system of immuno-assay (EASI assay) utilising self assembled monolayer modified electrodes. | 2001-12 |
|
| Vitellogenin induction in painted turtle, Chrysemys picta, as a biomarker of exposure to environmental levels of estradiol. | 2001-11-01 |
|
| Applications of liquid chromatography-tandem mass spectrometry in drug and biomedical analyses. | 2001-11 |
|
| Lamotrigine plasma levels reduced by oral contraceptives. | 2001-11 |
|
| Fluorogenic assay for beta-glucuronidase using microchip-based capillary electrophoresis. | 2001-10-05 |
|
| Glucuronidation of nonylphenol and octylphenol eliminates their ability to activate transcription via the estrogen receptor. | 2001-10 |
|
| HPLC/1H NMR spectroscopic studies of the reactive alpha-1-O-acyl isomer formed during acyl migration of S-naproxen beta-1-O-acyl glucuronide. | 2001-10 |
|
| Hydrolysis of conjugated metabolites of buprenorphine. I. The quantitative enzymatic hydrolysis of buprenorphine-3-beta-D-glucuronide in human urine. | 2001-10 |
|
| Tertiary N-glucuronides of clozapine and its metabolite desmethylclozapine in patient urine. | 2001-10 |
|
| Single amino acid substitution of rat MRP2 results in acquired transport activity for taurocholate. | 2001-10 |
|
| Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans. | 2001-09-21 |
|
| Functional characterization of human organic anion transporting polypeptide B (OATP-B) in comparison with liver-specific OATP-C. | 2001-09 |
|
| Search for metabolites of ecteinascidin 743, a novel, marine-derived, anti-cancer agent, in man. | 2001-09 |
|
| Mass spectrometry of steroid glucuronide conjugates. II-Electron impact fragmentation of 3-keto-4-en- and 3-keto-5alpha-steroid-17-O-beta glucuronides and 5alpha-steroid-3alpha,17beta-diol 3- and 17-glucuronides. | 2001-09 |
|
| [Biological monitoring of occupational exposure to sevoflurane]. | 2001-08-23 |
|
| Quantitation of entacapone glucuronide in rat plasma by on-line coupled restricted access media column and liquid chromatography-tandem mass spectrometry. | 2001-08-15 |
|
| Importance of vacutainer selection in forensic toxicological analysis of drugs of abuse. | 2001-08-14 |
|
| Investigation into some aspects of EMIT d.a.u., TLC, and GC-MS urinalysis of bromazepam. | 2001-08-14 |
|
| Intestinal absorption of rutin in free and conjugated forms. | 2001-08-01 |
|
| Simultaneous determination of morphine and its glucuronides in rat hair and rat plasma by reversed-phase liquid chromatography with electrospray ionization mass spectrometry. | 2001-08 |
|
| Identification of the major metabolites of prochloraz in rainbow trout by liquid chromatography and tandem mass spectrometry. | 2001-08 |
|
| The effect of selective bowel decontamination on the pharmacokinetics of mycophenolate mofetil in liver transplant recipients. | 2001-08 |
|
| Metabolism of orally administered androstenedione in young men. | 2001-08 |
|
| Effects of anticancer drugs on the metabolism of the anticancer drug 5,6-dimethylxanthenone-4-acetic (DMXAA) by human liver microsomes. | 2001-08 |
|
| Bisphenol a glucuronide, a major metabolite in rat bile after liver perfusion. | 2001-08 |
|
| Metabolic fate of 2,4-dichloroaniline, prochloraz and nonylphenol diethoxylate in rainbow trout: a comparative in vivo/in vitro approach. | 2001-08 |
|
| Functional expression of multidrug resistance protein 1 in Pichia pastoris. | 2001-07-27 |
|
| Transport of the beta -O-glucuronide conjugate of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by the multidrug resistance protein 1 (MRP1). Requirement for glutathione or a non-sulfur-containing analog. | 2001-07-27 |
|
| Determination of the chemical structure of the capsular polysaccharide of strain B33, a fast-growing soya bean-nodulating bacterium isolated from an arid region of China. | 2001-07-15 |
|
| Cisapride raises the bioavailability of paracetamol by inhibiting its glucuronidation in man. | 2001-07 |
|
| Bexarotene metabolism in rat, dog, and human, synthesis of oxidative metabolites, and in vitro activity at retinoid receptors. | 2001-07 |
|
| N-glucuronidation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and N_hydroxy-PhIP by specific human UDP-glucuronosyltransferases. | 2001-07 |
|
| Isolation of an unknown metabolite of the non-steroidal anti-inflammatory drug etodolac and its identification as 5-hydroxy etodolac. | 2001-07 |
|
| Synthesis, high-performance liquid chromatography-nuclear magnetic resonance characterization and pharmacokinetics in mice of CD271 glucuronide. | 2001-06-05 |
|
| Disposition of naproxen, naproxen acyl glucuronide and its rearrangement isomers in the isolated perfused rat liver. | 2001-06 |
|
| GC-FID as a primary method for establishing the purity of organic CRMs used for drugs in sport analysis. | 2001-06 |
|
| Analysis of urinary metabolites of tea catechins by liquid chromatography/electrospray ionization mass spectrometry. | 2001-06 |
|
| Establishment of the transformants expressing human cytochrome P450 subtypes in HepG2, and their applications on drug metabolism and toxicology. | 2001-06 |
|
| Isolation and identification of clozapine metabolites in patient urine. | 2001-06 |
|
| Hyperactivity and alopecia associated with ingestion of valproic acid in a cat. | 2001-05-15 |
|
| High-performance liquid chromatographic method combining radiochemical and ultraviolet detection for determination of low activities of uridine 5'-diphosphate-glucuronosyltransferase. | 2001-05-15 |
|
| Biotransformation of MTBE, ETBE, and TAME after inhalation or ingestion in rats and humans. | 2001-05 |
|
| The pharmacokinetics of glycyrrhizic acid evaluated by physiologically based pharmacokinetic modeling. | 2001-05 |
|
| Identification and reactivity of the major metabolite (beta-1-glucuronide) of the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in humans. | 2001-05 |
|
| Probenecid-associated alterations in valproic acid pharmacokinetics in rats: can in vivo disposition of valproate glucuronide be predicted from in vitro formation data? | 2001-05 |
|
| The detection of psilocin in human urine. | 2001-05 |
|
| Rapid and specific detection of hydroxyl radical using an ultraweak chemiluminescence analyzer and a low-level chemiluminescence emitter: application to hydroxyl radical-scavenging ability of aqueous extracts of Food constituents. | 2001-05 |
|
| Preparation of pyridine-N-glucuronides of tobacco-specific nitrosamines. | 2001-05 |
|
| Mechanisms of cancer chemoprevention by curcumin. | 2001-04 |
|
| Metabolism of bisphenol A in isolated rat hepatocytes and oestrogenic activity of a hydroxylated metabolite in MCF-7 human breast cancer cells. | 2001-03 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Tue Apr 01 19:26:34 GMT 2025
by
admin
on
Tue Apr 01 19:26:34 GMT 2025
|
| Record UNII |
QV7V2WC3TT
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
94108-04-0
Created by
admin on Tue Apr 01 19:26:34 GMT 2025 , Edited by admin on Tue Apr 01 19:26:34 GMT 2025
|
PRIMARY | |||
|
QV7V2WC3TT
Created by
admin on Tue Apr 01 19:26:34 GMT 2025 , Edited by admin on Tue Apr 01 19:26:34 GMT 2025
|
PRIMARY | |||
|
100000181267
Created by
admin on Tue Apr 01 19:26:34 GMT 2025 , Edited by admin on Tue Apr 01 19:26:34 GMT 2025
|
PRIMARY | |||
|
302-341-3
Created by
admin on Tue Apr 01 19:26:34 GMT 2025 , Edited by admin on Tue Apr 01 19:26:34 GMT 2025
|
PRIMARY | |||
|
44148640
Created by
admin on Tue Apr 01 19:26:34 GMT 2025 , Edited by admin on Tue Apr 01 19:26:34 GMT 2025
|
PRIMARY | |||
|
95444-99-8
Created by
admin on Tue Apr 01 19:26:34 GMT 2025 , Edited by admin on Tue Apr 01 19:26:34 GMT 2025
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
DTXSID60240561
Created by
admin on Tue Apr 01 19:26:34 GMT 2025 , Edited by admin on Tue Apr 01 19:26:34 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
|
||
|
|
PARENT -> SALT/SOLVATE |
|